UPDATE – Ikena Oncology Announces Strategic Update
PremiumPress ReleasesUPDATE – Ikena Oncology Announces Strategic Update
4M ago
iKena Oncology gains following workforce reduction, review of alternatives
Premium
The Fly
iKena Oncology gains following workforce reduction, review of alternatives
4M ago
iKena discontinues IK-930 and reduces workforce by 53%, to review alternatives
Premium
The Fly
iKena discontinues IK-930 and reduces workforce by 53%, to review alternatives
4M ago
iKena Oncology expects cash to meet operating requirements into 2H26
PremiumThe FlyiKena Oncology expects cash to meet operating requirements into 2H26
6M ago
iKena Oncology reports Q4 EPS (41c), consensus (43c)
Premium
The Fly
iKena Oncology reports Q4 EPS (41c), consensus (43c)
6M ago
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
Premium
Press Releases
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
6M ago
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
PremiumPress ReleasesIkena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
7M ago
Ikena Oncology Inc trading resumes
Premium
The Fly
Ikena Oncology Inc trading resumes
8M ago
iKena cuts 35% of workforce to focus on IK-930 and IK-595, to extend runway
Premium
The Fly
iKena cuts 35% of workforce to focus on IK-930 and IK-595, to extend runway
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100